Stem cell optimization for Parkinson's and related conditions
Part of Brain & nervous system clinical trials.
This trial tests a stem cell treatment to see if it can improve symptoms in people with Parkinson's disease or other similar conditions, like dementia with Lewy bodies or multiple system atrophy. It involves an injection of stem cells harvested from your own bone marrow.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 40 and 75 years old.
- You have been diagnosed with Parkinson's disease or another parkinsonism disorder (like PSP, MSA, or CBD) for 6 years or less.
- You can walk at least 25 meters (about the length of a bus) without help.
- You have stable health with no major changes in the last 60 days.
- You have no history of a brain surgery for your condition, recent cancer, or serious heart or kidney problems.
- You are willing to undergo bone marrow harvesting (like a donation) and have no blood clotting disorder.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new stem cell treatment for people with Parkinson's disease. It's for those whose symptoms affect daily life and who still respond to levodopa but find it less effective over time.
This trial tests whether transplanting specially grown cells (DopaCell) into the brain can safely help people with moderate Parkinson's disease whose symptoms aren't well controlled by medication. The cells are intended to produce dopamine, the chemical that Parkinson's affects.
This trial tests a new cell therapy, NouvNeu001, for people with Parkinson's disease who have had symptoms for at least 4 years and are having trouble with their current medications. The goal is to see if this treatment is safe and can improve motor symptoms that are not well controlled.
This trial tests whether implanting your own stem cells (made into dopamine-producing brain cells) can improve Parkinson's motor symptoms. You would need to be a candidate for brain surgery and have a stable medication routine.
This Phase 1 study tests whether transplanting your own processed cells (from you) is safe and potentially helpful for people with Parkinson’s disease. Participants are carefully selected based on symptom stage, medication stability, brain scans, and depression/mental function tests.
This trial uses special stem cells (made from skin or blood cells) to replace damaged brain cells in people with Parkinson's. The goal is to see if these cells can improve movement and reduce symptoms.
Hear when a new Atypical Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.